Femasys Inc.
FEMY•NASDAQ•Healthcare•Medical Instruments & Supplies

About Femasys

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.femasys.com
Phone770 500 3910
Address
3950 Johns Creek Court, Suite 100 Suwanee, Georgia 30024 United States

Corporate Identifiers

CIK0001339005
CUSIP31447E105
ISINUS31447E1055
EIN11-3713499
SIC3841

Leadership Team & Key Executives

Kathy Lee-Sepsick M.B.A.
Founder, President, Chief Executive Officer and Director
Dov Elefant
Chief Financial Officer
Mary An Merchant J.D., Ph.D.
Vice President of Counsel and Intellectual Property
Naomi Phaneuf
Vice President of Marketing
Benjamin Dings
Vice President of Sales
Dr. Jeffrey Marcus M.D., M.S.
Chief Medical Advisor
Christine Thomas
Senior Vice President of Regulatory and Clinical Affairs
Dr. James H. Liu M.D.
Chief Medical Officer
Kelley Nicholas
Chief Commercial Officer